FI945596A7 - Kvartäärisiä typpipitoisia fosfonaattiyhdisteitä epänormaalin kalsium- ja fosfaattiyhdisteitä epänormaalin kalsium- ja fosfaattiaineenvaihdunnan sekä hammaskiven ja hammastäplän hoitamiseksi - Google Patents
Kvartäärisiä typpipitoisia fosfonaattiyhdisteitä epänormaalin kalsium- ja fosfaattiyhdisteitä epänormaalin kalsium- ja fosfaattiaineenvaihdunnan sekä hammaskiven ja hammastäplän hoitamiseksi Download PDFInfo
- Publication number
- FI945596A7 FI945596A7 FI945596A FI945596A FI945596A7 FI 945596 A7 FI945596 A7 FI 945596A7 FI 945596 A FI945596 A FI 945596A FI 945596 A FI945596 A FI 945596A FI 945596 A7 FI945596 A7 FI 945596A7
- Authority
- FI
- Finland
- Prior art keywords
- dental
- treatment
- well
- quaternary nitrogen
- phosphonate compounds
- Prior art date
Links
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title 1
- 208000006558 Dental Calculus Diseases 0.000 title 1
- 208000002064 Dental Plaque Diseases 0.000 title 1
- 229910019142 PO4 Inorganic materials 0.000 title 1
- 206010044029 Tooth deposit Diseases 0.000 title 1
- 230000002159 abnormal effect Effects 0.000 title 1
- 229910052791 calcium Inorganic materials 0.000 title 1
- 239000011575 calcium Substances 0.000 title 1
- 230000004060 metabolic process Effects 0.000 title 1
- -1 nitrogen-containing phosphonate compounds Chemical class 0.000 title 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 title 1
- 239000010452 phosphate Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/5765—Six-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89088592A | 1992-05-29 | 1992-05-29 | |
| US08/052,695 US5391743A (en) | 1992-05-29 | 1993-04-30 | Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental calculus and plaque |
| PCT/US1993/005043 WO1993024498A1 (en) | 1992-05-29 | 1993-05-27 | Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI945596A0 FI945596A0 (fi) | 1994-11-28 |
| FI945596A7 true FI945596A7 (fi) | 1995-01-25 |
Family
ID=26730954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI945596A FI945596A7 (fi) | 1992-05-29 | 1994-11-28 | Kvartäärisiä typpipitoisia fosfonaattiyhdisteitä epänormaalin kalsium- ja fosfaattiyhdisteitä epänormaalin kalsium- ja fosfaattiaineenvaihdunnan sekä hammaskiven ja hammastäplän hoitamiseksi |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5770586A (fi) |
| EP (1) | EP0646119B1 (fi) |
| JP (1) | JPH07506569A (fi) |
| CN (1) | CN1042031C (fi) |
| AT (1) | ATE168379T1 (fi) |
| AU (1) | AU662991B2 (fi) |
| CA (1) | CA2136825C (fi) |
| CZ (1) | CZ297094A3 (fi) |
| DE (1) | DE69319732T2 (fi) |
| DK (1) | DK0646119T3 (fi) |
| ES (1) | ES2118967T3 (fi) |
| FI (1) | FI945596A7 (fi) |
| HU (1) | HUT72061A (fi) |
| IL (1) | IL105835A (fi) |
| MX (1) | MX9303243A (fi) |
| NO (1) | NO307055B1 (fi) |
| NZ (1) | NZ253541A (fi) |
| PH (1) | PH31246A (fi) |
| PL (1) | PL174761B1 (fi) |
| RU (1) | RU2126414C1 (fi) |
| SK (1) | SK144894A3 (fi) |
| WO (1) | WO1993024498A1 (fi) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993024500A1 (en) * | 1992-05-29 | 1993-12-09 | The Procter & Gamble Pharmaceuticals, Inc. | Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism |
| US5451401A (en) * | 1993-09-29 | 1995-09-19 | The Procter & Gamble Company | Diphosphonic acid esters as tartar control agents |
| WO1999033473A1 (fr) * | 1997-12-25 | 1999-07-08 | Toray Industries, Inc. | Remedes contre les maladies intramedullaires |
| CN101125864A (zh) * | 1998-09-09 | 2008-02-20 | 症变治疗公司 | 新的果糖1,6-二磷酸酶的杂芳族抑制剂 |
| EP1127578A4 (en) * | 1998-10-28 | 2004-12-15 | Sankyo Co | MEDICINE FOR BONE METABOLIC DEVIATIONS |
| CN100349574C (zh) * | 1999-07-19 | 2007-11-21 | 东丽株式会社 | 牙周疾病用剂 |
| PL194770B1 (pl) * | 2001-03-19 | 2007-07-31 | Adamed Sp Z Oo | Sposób wytwarzania kwasu rizedronowego |
| CZ2004690A3 (cs) * | 2001-12-21 | 2004-09-15 | The Procter & Gamble Company | Souprava a způsob jejího použití k léčbě kostních chorob |
| FR2838339B1 (fr) * | 2002-04-12 | 2005-06-24 | Univ Angers | Derives poly-phosphonates pour compositions dentifrices |
| US20040086581A1 (en) * | 2002-11-06 | 2004-05-06 | Jones Edwin B. | Bio-energetic joint and arthritis pain formula |
| FR2959667B1 (fr) * | 2010-05-10 | 2016-01-01 | Oreal | Composition cosmetique de maquillage et/ou de soin |
| CN110123662A (zh) * | 2019-04-30 | 2019-08-16 | 杭州伊瑟奇生物科技有限公司 | 基于电离剥离效果的牙胶及对口腔细菌和牙垢的剥离方法 |
| IL279966A (en) * | 2021-01-05 | 2022-08-01 | O Y M Innovation Ltd | Phosphonates and n-halamines compositions for tartar removal |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3683080A (en) * | 1970-08-28 | 1972-08-08 | Procter & Gamble | Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue |
| US4208401A (en) * | 1977-08-19 | 1980-06-17 | Colgate-Palmolive Company | Quaternary ammonium alkylene diphosphonate anti-calculus agents |
| DE2745083C2 (de) * | 1977-10-07 | 1985-05-02 | Henkel KGaA, 4000 Düsseldorf | Hydroxydiphosphonsäuren und Verfahren zu deren Herstellung |
| US4230700A (en) * | 1977-12-07 | 1980-10-28 | The Procter & Gamble Company | Methods for inhibiting mobilization of calcium phosphate in animal tissue |
| DE3016289A1 (de) * | 1980-04-28 | 1981-10-29 | Henkel KGaA, 4000 Düsseldorf | Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren |
| FR2531088B1 (fr) * | 1982-07-29 | 1987-08-28 | Sanofi Sa | Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation |
| FR2558837B1 (fr) * | 1984-01-26 | 1986-06-27 | Sanofi Sa | Derives de l'acide methylenediphosphonique, procede d'obtention et medicaments antirhumatismaux les contenant |
| DE3428524A1 (de) * | 1984-08-02 | 1986-02-13 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| PH27078A (en) * | 1984-12-21 | 1993-02-01 | Procter & Gamble | Pharmaceutical compositions containing geminal diphosphonates |
| IL77243A (en) * | 1984-12-21 | 1996-11-14 | Procter & Gamble | Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds |
| US5104863A (en) * | 1984-12-21 | 1992-04-14 | The Procter & Gamble Company | Certain bicycloalkane and azabicycloalkane-1,1-diphosphonic acid derivatives useful for treating diseases associated with abnormal calcium and phosphate metabolism |
| US4687768A (en) * | 1984-12-21 | 1987-08-18 | The Procter & Gamble Company | Certain hexahydroindan-2,2-diphosphonic acids useful in treating diseases associated with abnormal calcium and phosphate metabolism |
| DE3776880D1 (de) * | 1986-11-21 | 1992-04-02 | Ciba Geigy Ag | Neue substituierte alkandiphosphonsaeuren. |
| DE3640938A1 (de) * | 1986-11-29 | 1988-06-01 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindung enthaltende arzneimittel |
| US4868164A (en) * | 1986-12-19 | 1989-09-19 | Norwich Eaton Pharmaceuticals, Inc. | Octahydro-pyridine diphosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
| US5071840A (en) * | 1986-12-19 | 1991-12-10 | Norwich Eaton Pharmaceuticals, Inc. | Certain heterocyclic substituted diphosphonate compounds pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism |
| IL86951A (en) * | 1987-07-06 | 1996-07-23 | Procter & Gamble Pharma | Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them |
| EP0320455B1 (de) * | 1987-12-11 | 1993-06-09 | Ciba-Geigy Ag | Araliphatylaminoalkandiphosphonsäuren |
| JPH01258695A (ja) * | 1988-04-07 | 1989-10-16 | Yamanouchi Pharmaceut Co Ltd | （ピラゾリルアミノ）メチレンビス（ホスホン酸）誘導体及びその医薬 |
| GB8808138D0 (en) * | 1988-04-07 | 1988-05-11 | Leo Pharm Prod Ltd | Chemical compounds |
| US4933472A (en) * | 1988-04-08 | 1990-06-12 | Yamanouchi Pharmaceutical Co., Ltd. | Substituted aminomethylenebis(phosphonic acid) derivatives |
| DE3822650A1 (de) * | 1988-07-05 | 1990-02-01 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| TW198039B (fi) * | 1988-11-28 | 1993-01-11 | Ciba Geigy Ag | |
| DE69002328T2 (de) * | 1989-04-03 | 1993-12-09 | Upjohn Co | Geminale bisphosphonsäuren und deren derivate als antiarthritische mittel. |
| DE4011777A1 (de) * | 1989-04-14 | 1990-10-18 | Ciba Geigy Ag | N-trisubstituierte aminoalkandiphosphonsaeuren |
| US4922007A (en) * | 1989-06-09 | 1990-05-01 | Merck & Co., Inc. | Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof |
| JPH05507061A (ja) * | 1990-01-12 | 1993-10-14 | ローヌ―プーラン ローラー インターナショナル （ホウルディングス）インコーポレイテッド | １―アゼチジル及び１―ヘキサメチレンイミンアルキルまたはアリールビスホスホン酸及び医薬としてのその使用 |
| SK144494A3 (en) * | 1992-05-29 | 1995-05-10 | Procter & Gamble Pharma | Sulfur-containing phosphate compounds and their using in pharmaceutical compound for treating abnormal calcium and phosphate metabolism |
-
1993
- 1993-05-27 JP JP5517834A patent/JPH07506569A/ja active Pending
- 1993-05-27 DK DK93914197T patent/DK0646119T3/da active
- 1993-05-27 SK SK1448-94A patent/SK144894A3/sk unknown
- 1993-05-27 DE DE69319732T patent/DE69319732T2/de not_active Expired - Fee Related
- 1993-05-27 CA CA002136825A patent/CA2136825C/en not_active Expired - Fee Related
- 1993-05-27 PL PL93306382A patent/PL174761B1/pl unknown
- 1993-05-27 WO PCT/US1993/005043 patent/WO1993024498A1/en not_active Ceased
- 1993-05-27 AU AU43945/93A patent/AU662991B2/en not_active Ceased
- 1993-05-27 CZ CZ942970A patent/CZ297094A3/cs unknown
- 1993-05-27 RU RU94046106A patent/RU2126414C1/ru active
- 1993-05-27 AT AT93914197T patent/ATE168379T1/de active
- 1993-05-27 ES ES93914197T patent/ES2118967T3/es not_active Expired - Lifetime
- 1993-05-27 EP EP93914197A patent/EP0646119B1/en not_active Expired - Lifetime
- 1993-05-27 NZ NZ253541A patent/NZ253541A/en unknown
- 1993-05-27 HU HU9403412A patent/HUT72061A/hu unknown
- 1993-05-28 IL IL10583593A patent/IL105835A/xx not_active IP Right Cessation
- 1993-05-28 PH PH46272A patent/PH31246A/en unknown
- 1993-05-29 CN CN93108278A patent/CN1042031C/zh not_active Expired - Fee Related
- 1993-05-31 MX MX9303243A patent/MX9303243A/es not_active IP Right Cessation
-
1994
- 1994-11-03 US US08/333,652 patent/US5770586A/en not_active Expired - Fee Related
- 1994-11-25 NO NO944516A patent/NO307055B1/no not_active IP Right Cessation
- 1994-11-28 FI FI945596A patent/FI945596A7/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2126414C1 (ru) | 1999-02-20 |
| EP0646119A1 (en) | 1995-04-05 |
| MX9303243A (es) | 1994-05-31 |
| PL174761B1 (pl) | 1998-09-30 |
| JPH07506569A (ja) | 1995-07-20 |
| CA2136825C (en) | 1997-10-28 |
| EP0646119B1 (en) | 1998-07-15 |
| NO944516L (no) | 1995-01-27 |
| US5770586A (en) | 1998-06-23 |
| AU662991B2 (en) | 1995-09-21 |
| FI945596A0 (fi) | 1994-11-28 |
| ES2118967T3 (es) | 1998-10-01 |
| HUT72061A (en) | 1996-03-28 |
| IL105835A0 (en) | 1993-09-22 |
| WO1993024498A1 (en) | 1993-12-09 |
| NZ253541A (en) | 1997-01-29 |
| ATE168379T1 (de) | 1998-08-15 |
| SK144894A3 (en) | 1995-07-11 |
| HU9403412D0 (en) | 1995-02-28 |
| PH31246A (en) | 1998-06-18 |
| CZ297094A3 (en) | 1995-12-13 |
| AU4394593A (en) | 1993-12-30 |
| CN1042031C (zh) | 1999-02-10 |
| HK1013075A1 (en) | 1999-08-13 |
| NO307055B1 (no) | 2000-01-31 |
| DE69319732T2 (de) | 1999-02-11 |
| CN1088213A (zh) | 1994-06-22 |
| IL105835A (en) | 2000-08-13 |
| DK0646119T3 (da) | 1998-12-14 |
| DE69319732D1 (de) | 1998-08-20 |
| NO944516D0 (no) | 1994-11-25 |
| RU94046106A (ru) | 1996-09-27 |
| CA2136825A1 (en) | 1993-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA933763B (en) | Novel quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental caculus and plaque. | |
| FI945599L (fi) | Fosfonokarboksylaattiyhdisteitä epänormaalin kalsium- ja fosfaattiaineenvaihdunnan hoitamiseksi | |
| FI945596A7 (fi) | Kvartäärisiä typpipitoisia fosfonaattiyhdisteitä epänormaalin kalsium- ja fosfaattiyhdisteitä epänormaalin kalsium- ja fosfaattiaineenvaihdunnan sekä hammaskiven ja hammastäplän hoitamiseksi | |
| FI945595A7 (fi) | Tiosubstituoituja typpipitoisia heterosyklisiä fosfonaattiyhdisteitä e pänormaalin kalsium- ja fosfaattiaineenvaihdunnan hoitamiseksi | |
| DE69721556D1 (de) | Mundwasser mit kalzium- und phosphationen in einer übersättigten lösung | |
| DE69405919D1 (de) | Zusammensetzungen zur Behandlung von Keratinfasern | |
| KR950010156B1 (en) | Pharmaceutical dosage unit for the prevention or treatment of climacteric complaints | |
| FI962685L (fi) | 2,3-diaryyli-1-bentsopyraanijohdannaisten käyttö lääkkeen valmistamiseksi luukadon ja osteoporoosin hoitamiseksi ja estämiseksi | |
| FI945593A7 (fi) | Rikkipitoisia fosfonaattiyhdisteitä epänormaalin kalsium- ja fosfaattiaineenvaihdunnan hoitamiseksi | |
| BG102716A (en) | Method for the treatment of cardiac insufficiency by means of formulations opposing the endotheline | |
| FI945597L (fi) | Kvartäärisiä typpipitoisia fosfonaattiyhdisteitä epänormaalin kalsium- ja fosfaattiaineenvaihdunnan hoitamiseksi | |
| NO178287C (no) | Fremgangsmåte for desinfeksjon av medisinske avstöpningsmasser | |
| FI945594A7 (fi) | Tiosubstituoituja syklisiä fosfonaattiyhdisteitä epänormaalin kalsium- ja fosfaattiaineenvaihdunnan hoitamiseksi | |
| FI945592A7 (fi) | Fosfonosulfonaattiyhdisteitä epänormaalin kalsium- ja fosfaattiaineenv aihdunnan hoitamiseksi | |
| NO982562D0 (no) | Sammensetning for behandling av smerte | |
| FI945598A7 (fi) | Kvartäärisiä typpipitoisia fosfonaattiyhdisteitä epänormaalin kalsium- ja fosfaattiaineenvaihdunnan hoitamiseksi | |
| IL115223A0 (en) | Preparation containing antiresorptive compounds for use in the treatment of osteoporosis | |
| NO944514D0 (no) | Kvarternære nitrogen-inneholdende fosfonatforbindelser for behandling av abnormal kalsium- og fosfatmetabolisme | |
| FI970713A7 (fi) | Menetelmiä hampaiden ja suun luuston kunnon ylläpitämiseksi | |
| ZA933765B (en) | Novel quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methodsfor treating abnormal calcium and phosphate metabolism. | |
| NO180103C (no) | Fremgangsmåte for direktetilpasning av proteser | |
| IT1244714B (it) | Uso della benzidamina per il trattamento della placca dentaria | |
| BG99596A (en) | Preparation for the treatment of gums and teeth | |
| BR9102169A (pt) | Aparelho para esterilizacao de canais dentarios | |
| NO945058D0 (no) | Anvendelse av fosfonater for behandling av osteoporose |